Geneoscopy Appoints Matt Sargent as Chief Commercial Officer and Tyler Aldredge as Vice President of Operations
Position
Chief Commercial Officer
Company
Geneoscopy
St. LouisBiotechnologyHealthcareHealth CareTherapeuticsHealth DiagnosticsDescription
Geneoscopy, Inc. has appointed Matt Sargent as Chief Commercial Officer and Tyler Aldredge as Vice President of Operations to support the commercialization of ColoSense and expand the company's RNA platform to inflammatory bowel disease (IBD) diagnostics. Both appointees will play critical roles in bringing ColoSense to market and advancing precision diagnostics for IBD.
Quick answer
Geneoscopy Appoints Matt Sargent as Chief Commercial Officer and Tyler Aldredge as Vice President of Operations (May 15, 2024). Geneoscopy is based in St. Louis, Missouri, United States.
- Who is the new Chief Commercial Officer at Geneoscopy?
- Geneoscopy named Matt Sargent Chief Commercial Officer, announced May 15, 2024.
- What did Geneoscopy announce on May 15, 2024?
- Geneoscopy, Inc. has appointed Matt Sargent as Chief Commercial Officer and Tyler Aldredge as Vice President of Operations to support the commercialization of ColoSense and expand the company's RNA platform to inflammatory bowel disease (IBD) diagnostics. Both appointees will play critical roles in bringing ColoSense to market and advancing precision diagnostics for IBD.
- What does Geneoscopy do?
- Geneoscopy is a life sciences company with the mission to empower patients and providers to transform gastrointestinal health through innovative diagnostics.
- Where is Geneoscopy based?
- Geneoscopy is based in St. Louis, Missouri, United States.
- Which similar companies made leadership changes around the same time?
- Wave Life Sciences (May 10, 2024), EyePoint, Inc. (May 9, 2024), Crispr Therapeutics (May 24, 2024) and Lykos Therapeutics (May 3, 2024) also announced leadership changes within 45 days of Geneoscopy.
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Wave Life Sciences Appoints Erik Ingelsson as Chief Scientific Officer (May 10, 2024)
- EyePoint Pharmaceuticals, Inc. Appoints Isabelle Lefebvre as Chief Regulatory Officer (May 9, 2024)
- CRISPR Therapeutics Appoints Naimish Patel as Chief Medical Officer and Julianne Bruno as Chief Operating Officer (May 24, 2024)
- Lykos Therapeutics Appoints Allison Rosenthal as Chief Commercial Officer and Coy Stout as Vice President of Market Access (May 3, 2024)
- Crinetics Pharmaceuticals Appoints Robert M. Cuddihy, M.D. as Senior Vice President of Medical Affairs (May 30, 2024)
- Recursion Pharmaceuticals Appoints Najat Khan as Chief Commercial Officer and Head of R&D (April 19, 2024)
Who to call at Geneoscopy, and when
A new leader at Geneoscopy brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Geneoscopy raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Geneoscopy, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Geneoscopy. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Geneoscopy changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Geneoscopy changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.